Orange Book product · Generic (ANDA)
DESVENLAFAXINE SUCCINATE
DESVENLAFAXINE SUCCINATE
At a glance
Jun 29, 2015
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 29, 2015
11 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
DESVENLAFAXINE SUCCINATE
Strength
EQ 50MG BASE
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
ANDA 204095
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DESVENLAFAXINE SUCCINATE
- 2014PRISTIQBrand (NDA)
NDA 021992 · PF PRISM CV
- 2026DESVENLAFAXINE SUCCINATEGeneric (ANDA)
ANDA 220460 · YICHANG HUMANWELL
- 2025DESVENLAFAXINE SUCCINATEGeneric (ANDA)
ANDA 211427 · MACLEODS PHARMS LTD
- 2023DESVENLAFAXINE SUCCINATEGeneric (ANDA)
ANDA 204028 · RUBICON RESEARCH
- 2022DESVENLAFAXINE SUCCINATEGeneric (ANDA)
ANDA 204020 · ZYDUS PHARMS
- 2022DESVENLAFAXINE SUCCINATEGeneric (ANDA)
ANDA 204172 · LUPIN
- 2020DESVENLAFAXINE SUCCINATEGeneric (ANDA)
ANDA 210014 · YICHANG HUMANWELL
- 2019DESVENLAFAXINE SUCCINATEGeneric (ANDA)
ANDA 204805 · PLATINUM
- 2018DESVENLAFAXINE SUCCINATEGeneric (ANDA)
ANDA 204003 · ALEMBIC
- 2016DESVENLAFAXINE SUCCINATEGeneric (ANDA)
ANDA 204065 · ACTAVIS LABS FL
- 2016DESVENLAFAXINE SUCCINATEGeneric (ANDA)
ANDA 204083 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
